TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill July 12, 1985